Bvf Partners L P/Il - Insider Trading & Ownership

Entity
Company
Location
44 Montgomery St., 40 Th Floor, San Francisco, CA
Summary
The estimated value of insider holdings of Bvf Partners L P/Il is at least $128M dollars as of December 17, 2024. Bvf Partners L P/Il is the Director, 10%+ Owner of MoonLake Immunotherapeutics and owns shares of MoonLake Immunotherapeutics (MLTX) stock worth about $64.4M. Bvf Partners L P/Il is the Director, Other* of Kymera Therapeutics, Inc. and owns shares of Kymera Therapeutics, Inc. (KYMR) stock worth about $20.1M. Bvf Partners L P/Il is the 10%+ Owner of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $10.9M. Bvf Partners L P/Il is the 10%+ Owner of Merus N.V. and owns shares of Merus N.V. (MRUS) stock worth about $6.47M. Bvf Partners L P/Il is the Director, Other* of Olema Pharmaceuticals, Inc. and owns shares of Olema Pharmaceuticals, Inc. (OLMA) stock worth about $6.15M. Bvf Partners L P/Il is the 10%+ Owner of Eledon Pharmaceuticals, Inc. and owns shares of Eledon Pharmaceuticals, Inc. (ELDN) stock worth about $4.05M. Bvf Partners L P/Il is the 10%+ Owner of ESSA Pharma Inc. and owns shares of ESSA Pharma Inc. (EPIX) stock worth about $3.58M. Bvf Partners L P/Il is the 10%+ Owner of Repare Therapeutics Inc. and owns shares of Repare Therapeutics Inc. (RPTX) stock worth about $2.96M. Bvf Partners L P/Il is the Other* of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. (THRD) stock worth about $2.53M. Bvf Partners L P/Il is the 10%+ Owner of Allakos Inc. and owns shares of Allakos Inc. (ALLK) stock worth about $2.14M. Bvf Partners L P/Il is the Director, Other*, 10%+ Owner of XOMA Corp and owns shares of XOMA Royalty Corp (XOMA) stock worth about $1.91M. Bvf Partners L P/Il is the Other* of 4D Molecular Therapeutics, Inc. and owns shares of 4D Molecular Therapeutics, Inc. (FDMT) stock worth about $1.44M. Bvf Partners L P/Il is the 10%+ Owner of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $799K. Bvf Partners L P/Il is the Other* of PIERIS PHARMACEUTICALS, INC. and owns shares of PIERIS PHARMACEUTICALS, INC. (PIRS) stock worth about $619K.
All Insider Reports
All Insider Reports

Ownership of Bvf Partners L P/Il

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MLTX MoonLake Immunotherapeutics Director, 10%+ Owner $64.4M -$100M -60.8% Oct 4, 2024
KYMR Kymera Therapeutics, Inc. Director, Other* $20.1M +$39.3M Aug 20, 2024
VSTM Verastem, Inc. 10%+ Owner $10.9M Jan 25, 2022
MRUS Merus N.V. 10%+ Owner $6.47M Oct 7, 2021
OLMA Olema Pharmaceuticals, Inc. Director, Other* $6.15M Dec 4, 2024
ELDN Eledon Pharmaceuticals, Inc. 10%+ Owner $4.05M +$17.3M Oct 29, 2024
EPIX ESSA Pharma Inc. 10%+ Owner $3.58M Jul 11, 2022
RPTX Repare Therapeutics Inc. 10%+ Owner $2.96M Nov 15, 2023
THRD Third Harmonic Bio, Inc. Other* $2.53M -$14.3M -85% Oct 29, 2024
ALLK Allakos Inc. 10%+ Owner $2.14M Jan 16, 2024
XOMA, XOMAO XOMA Royalty Corp Director, Other*, 10%+ Owner $1.91M May 17, 2023
FDMT 4D Molecular Therapeutics, Inc. Other* $1.44M Nov 8, 2024
CGEM Cullinan Therapeutics, Inc. 10%+ Owner $799K Jan 19, 2023
PIRS PIERIS PHARMACEUTICALS, INC. Other* $619K Dec 13, 2024
RAIN Rain Oncology Inc. Director, Other* $0 Jan 25, 2024
CTIC CTI BIOPHARMA CORP Director, Other*, 10%+ Owner Jun 26, 2023
ENGN, ENGNW enGene Holdings Inc. 10%+ Owner Oct 31, 2023
PNT POINT Biopharma Global Inc. Former 10% Owner Dec 18, 2023
GPCR Structure Therapeutics Inc. 10%+ Owner May 10, 2023

Insider Transactions Reported by Bvf Partners L P/Il:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.